Bristol-Myers"Bristol-Myers Squibb (BMY, NYSE, around $80...

STOCK WATCH HC B

November 20, 1991|By Opinions on stocks offered by investment experts. Compiled by Steve Halpern for Knight Ridder.

Bristol-Myers

"Bristol-Myers Squibb (BMY, NYSE, around $80) has become the world's second-largest drug firm," says Mariola Hagger of Kemper Securities.

"The company recently received FDA approval for Monopril, its once-a-day ACE inhibitor for hypertension. We also expect approval for Procef, an oral cephalosporin antibiotic, by year-end. Also, a very promising anti-cancer drug, Taxol, could be on the market as early as 1993. We look for earnings to rise 18 to 20 percent. We rate the stock a strong buy."

Office Depot

"Office Depot (ODEP, OTC, around $40) is the largest, most profitable, and fastest-growing company in the warehouse-format office products retailing segment," says James Thayer of Bear Stearns. The firm appears to be on track to achieve sizable increases in sales and earnings this year and next.

"For the current year, we expect the firm to earn 55 to 60 cents per share. In fiscal 1992, we look for earnings to double, as the economy improves and operations become more efficient."

Video Jukebox

"Video Jukebox (JUKE, OTC, around $2) is the country's first and only interactive TV network," says the Kon-Lin Letter of Rocky Point, N.Y.

"The network reaches over 12 million households via 165 channels. Viewers are able to choose -- on a pay-per-view basis via their telephones -- a specific music video to be shown on the network. Revenues in 1990 jumped 258 percent to $13.6 million. For the first half of 1991, sales rose 32 percent. We rate the stock a buy."

Superior Surgical

"Superior Surgical (SGC, AMEX, around $53) manufactures a wide range of uniforms, career apparel and accessories for the medical and health fields, as well as commercial and industrial markets," explains the Patient Investor of Chicago.

"The medical-related business has held up extremely well, due to the consistent, recession-resistant nature of this market. Weakness in the industrial segment led to a drop in third quarter earnings from 89 to 82 cents per share. But, we recommend purchase by long-term investors."

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.